Sotera Health Company (NASDAQ:SHC) Receives Average Recommendation of “Moderate Buy” from Brokerages

Sotera Health Company (NASDAQ:SHC) has received an average rating of “Moderate Buy” from the ten brokerages that are presently covering the company, Marketbeat Ratings reports. Three investment analysts have rated the stock with a hold rating and seven have given a buy rating to the company. The average 1-year price objective among brokers that have updated their coverage on the stock in the last year is $20.3333.

A number of brokerages recently issued reports on SHC. Piper Sandler reissued an “overweight” rating and set a $22.00 price target (down from $24.00) on shares of Sotera Health in a report on Wednesday, May 6th. Weiss Ratings downgraded shares of Sotera Health from a “hold (c)” rating to a “hold (c-)” rating in a report on Thursday. Citigroup increased their price target on shares of Sotera Health from $21.00 to $23.00 and gave the stock a “buy” rating in a report on Tuesday, February 24th. Zacks Research downgraded shares of Sotera Health from a “strong-buy” rating to a “hold” rating in a report on Friday, January 30th. Finally, Wall Street Zen downgraded shares of Sotera Health from a “strong-buy” rating to a “buy” rating in a report on Saturday, April 11th.

Insider Activity at Sotera Health

In other Sotera Health news, Director Gtcr Investment Xi Llc sold 12,735,301 shares of the stock in a transaction dated Wednesday, May 13th. The shares were sold at an average price of $15.17, for a total transaction of $193,194,516.17. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 15.36% of the stock is owned by company insiders.

Institutional Trading of Sotera Health

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in SHC. Sculptor Capital LP boosted its position in shares of Sotera Health by 3.4% during the 1st quarter. Sculptor Capital LP now owns 21,717,728 shares of the company’s stock worth $311,432,000 after purchasing an additional 717,728 shares in the last quarter. Vanguard Group Inc. boosted its position in shares of Sotera Health by 16.7% during the 4th quarter. Vanguard Group Inc. now owns 19,228,375 shares of the company’s stock worth $339,189,000 after purchasing an additional 2,756,583 shares in the last quarter. Sachem Head Capital Management LP boosted its position in shares of Sotera Health by 47.2% during the 4th quarter. Sachem Head Capital Management LP now owns 11,645,000 shares of the company’s stock worth $205,418,000 after purchasing an additional 3,735,000 shares in the last quarter. Janus Henderson Group PLC boosted its position in shares of Sotera Health by 35.3% during the 1st quarter. Janus Henderson Group PLC now owns 9,162,191 shares of the company’s stock worth $131,413,000 after purchasing an additional 2,390,132 shares in the last quarter. Finally, State Street Corp boosted its position in shares of Sotera Health by 21.0% during the 4th quarter. State Street Corp now owns 5,965,326 shares of the company’s stock worth $105,228,000 after purchasing an additional 1,035,457 shares in the last quarter. Institutional investors and hedge funds own 91.03% of the company’s stock.

Sotera Health Trading Down 0.3%

NASDAQ:SHC opened at $15.66 on Friday. The company’s 50 day moving average price is $14.98 and its 200-day moving average price is $16.39. Sotera Health has a 52 week low of $10.80 and a 52 week high of $19.85. The company has a quick ratio of 2.54, a current ratio of 2.82 and a debt-to-equity ratio of 3.56. The stock has a market cap of $4.47 billion, a price-to-earnings ratio of 38.20 and a beta of 1.82.

Sotera Health (NASDAQ:SHC) last issued its earnings results on Tuesday, May 5th. The company reported $0.18 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.17 by $0.01. Sotera Health had a net margin of 9.91% and a return on equity of 39.73%. The company had revenue of $280.05 million for the quarter, compared to analysts’ expectations of $270.78 million. During the same quarter last year, the company posted $0.14 earnings per share. The firm’s quarterly revenue was up 10.0% on a year-over-year basis. Sotera Health has set its FY 2026 guidance at 0.930-1.010 EPS. On average, equities research analysts forecast that Sotera Health will post 0.86 earnings per share for the current fiscal year.

Sotera Health Company Profile

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.